newsfilter
← Latest News
GlobeNewswire·

Immunovant to Present at Upcoming Investor Conferences

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (NASDAQ:IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that Pete